Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hyper
Sponsored by Aerovate Therapeutics
Active
$288.2K Funding
1 People
External
Related Topics
clinical trials,
pulmonary arterial hypertension,
drug efficacy,
safety evaluation
People
Franz Rischard
Principal Investigator (PI)
Medicine
﹒Professor